M&A Deal Summary |
|
|---|---|
| Date | 2015-08-11 |
| Target | AdeptBio |
| Sector | Life Science |
| Buyer(s) | Asterand Bioscience |
| Deal Type | Add-on Acquisition |
SEARCH BY
Asterand Bioscience is a provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists. Our mission is to provide human-based solutions to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| State: Tennessee M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2015 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-09-09 |
Stemgent - iPS Cell Business Unit
United States iPS cell research reagent products including mRNA reprogramming kit, xeno-free culture media, and specialty chemicals for cell differentiation, and has established a world-famous, proven and trusted brand in the iPS cell field. |
Sell | - |
